Relationship Between Central Venous Pressure, Cardiac Index, and Renal Function in Pediatric Heart Failure: a Pediatric Heart Transplant Society Study
- PMID: 40696166
- DOI: 10.1007/s00246-025-03956-9
Relationship Between Central Venous Pressure, Cardiac Index, and Renal Function in Pediatric Heart Failure: a Pediatric Heart Transplant Society Study
Abstract
Renal dysfunction (RD) is common in patients with heart failure with or without congenital heart disease, but the determinants of renal dysfunction are not well understood in children with heart failure. Low cardiac output is often discussed as a risk factor for RD.The purpose of this study was therefore to elucidate the relationship between renal function and hemodynamic parameters in children with heart failure. Children (age < 18, n = 3739) listed for HT in the PHTS database from 1993-2023 were included. Laboratory, clinical, hemodynamic, and demographic parameters were collected and analyzed for the study. RD was defined as eGFR less than 40 ml/min/1.73 m2 for patients younger than 2 years old, less than 60 ml/min/1.73 m2 for patients 2 years old and older. We assessed correlation between eGFR and hemodynamic parameters. Logistic regression was used to assess risk factors for renal dysfunction by etiologic cohort. The mean age was 7.2 ± 6.2 years, weight 27.78 ± 25.03 kg, male gender 58%, 39% with cardiomyopathy (CM) and 61% with congenital heart disease (CHD) including 21% with Fontan circulation. RD was present in 6% of the cohort.In CM cohort, high BMI (OR 1.057, 1.025-1.091), male gender (OR 2.08, 1.21-3.59), black race (OR 1.98, 1.17-3.36) and heart failure category of high cardiac index with high CVP compared to high cardiac index with low CVP (OR 2.34, 1.27-4.29) were significant predictors of renal dysfunction.In Fontan cohort, only BMI (OR 1.08, CI 1.023-1.134) was associated with renal dysfunction while none of the hemodynamic parameters predicted RD in CHD cohort.Lastly, RD at listing (OR 2.82, CI 1.50-5.28), weight at transplant (OR 1.00, CI 1.00-1.01), post-transplant mechanical circulatory support (OR 2.55, CI 1.04-6.26), and post-transplant dialysis (2.74, CI 1.106.84) were associated with RD at one-year post-transplant for the overall cohort. The relationship between various clinical and hemodynamic factors and renal dysfunction is complex in children with heart failure. Further, the study continued to show persistent impact of renal dysfunction at listing on post-transplant renal function. Improving understanding modifiable risk factors by type of heart disease as well as role of newer heart failure therapies is critical in reducing this significant morbidity.
Keywords: Cardiorenal syndrome; Heart failure; Outcomes; Pediatric cardiology; Renal dysfunction; Venous congestion.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: No relevant conflict of interest for any of the authors for the study
Similar articles
-
Systemic Inflammatory Response Syndrome.2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2. Cochrane Database Syst Rev. 2024. PMID: 39698949
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2. Cochrane Database Syst Rev. 2022. PMID: 36162822 Free PMC article.
References
-
- Halimi J-M et al (2022) Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study. Nephrol Dial Transplant 37(12):2386–2397 - PubMed
-
- Ronco C et al (2008) Cardiorenal Syndrome. J Am Coll Cardiol 52(19):1527–1539 - PubMed
-
- Rangaswami J et al (2019) Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American heart association. Circulation 139(16):e840–e878 - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous